A Pilot Study of Recombinant Human Relaxin (rhRlx) in Compensated Congestive Heart Failure
NCT00259116
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
18
Enrollment
INDUSTRY
Sponsor class
Conditions
Heart Failure, Congestive
Interventions
DRUG:
Relaxin
Sponsor
Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies